Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent حسب Mathieu Joos (20331128)

"…The antimicrobial activity of the hydrogel cannot solely be attributed to the resulting pH decrease of the suspension, as the presence of GA significantly increases the activity. …"

5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection. حسب Li Gao (131516)

الموضوعات:

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx حسب Teresa Fontán-Baselga (20392470)

"…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …"

Study selection criteria. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

PRISMA flow chart. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

Summary of post-treatment disease course measures from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

Summary of clinical efficacy of relevant PTSD treatments. حسب Filip Stanicic (17808254)

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. حسب Filip Stanicic (17808254)

Time course of Path Length, LFS and Velocity during postural training. حسب Cristina Dolciotti (16317330)

Training-induced changes in bipedal stance. حسب Cristina Dolciotti (16317330)

Time course of 95% Area, X and Y Amplitude Sway during postural training. حسب Cristina Dolciotti (16317330)

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. حسب Cristina Dolciotti (16317330)